Literature DB >> 25261203

TH1/TH2 cell differentiation and molecular signals.

Yuan Zhang1, Yaguang Zhang, Wangpeng Gu, Bing Sun.   

Abstract

The distinctive differentiated states of the CD4+ T helper cells are determined by the set of transcription factors and the genes transcribed by the transcription factors. In vitro induction models, the major determinants of the cytokines present during the T-cell receptor (TCR)-mediated activation process. IL-12 and IFN-γ make Naive CD4+ T cells highly express T-bet and STAT4 and differentiate to TH1 cells, while IL-4 make Naive CD4+ T cells highly express STAT6 and GATA3 and differentiated to TH2 cells. Even through T-bet and GATA3 are master regulators for TH1/TH2 cells differentiation. There are many other transcription factors, such as RUNX family proteins, IRF4, Dec2, Gfi1, Hlx, and JunB that can impair TH1/TH2 cells differentiation. In recent years, noncoding RNAs (microRNA and long noncoding RNA) join in the crowd. The leukocytes should migrate to the right place to show their impact. There are some successful strategies, which are revealed to targeting chemokines and their receptors, that have been developed to treat human immune-related diseases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25261203     DOI: 10.1007/978-94-017-9487-9_2

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  55 in total

Review 1.  Gut commensal bacteria, Paneth cells and their relations to radiation enteropathy.

Authors:  Yan-Li Gao; Li-Hong Shao; Li-Hua Dong; Peng-Yu Chang
Journal:  World J Stem Cells       Date:  2020-03-26       Impact factor: 5.326

2.  Imbalances in T Cell-Related Transcription Factors Among Patients with Hashimoto's Thyroiditis.

Authors:  Vahid Safdari; Ebrahim Alijani; Maryam Nemati; Abdollah Jafarzadeh
Journal:  Sultan Qaboos Univ Med J       Date:  2017-06-20

3.  NEAT1 regulates Th2 cell development by targeting STAT6 for degradation.

Authors:  Shuman Huang; Dong Dong; Yaqian Zhang; Zhuo Chen; Jing Geng; Yulin Zhao
Journal:  Cell Cycle       Date:  2019-01-17       Impact factor: 4.534

Review 4.  Tofacitinib: A New Oral Therapy for Psoriasis.

Authors:  Alexandra Azevedo; Tiago Torres
Journal:  Clin Drug Investig       Date:  2018-02       Impact factor: 2.859

Review 5.  T-cell involvement in sex differences in blood pressure control.

Authors:  G Ryan Crislip; Jennifer C Sullivan
Journal:  Clin Sci (Lond)       Date:  2016-05-01       Impact factor: 6.124

6.  Expression and pathological significance of CC chemokine receptor 7 and its ligands in the airway of asthmatic rats exposed to cigarette smoke.

Authors:  Jun-Feng Zhang; Yi Li; Ai-Zhen Zhang; Qian-Qian He; Yong-Cheng Du; Wen Cao
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

Review 7.  The MAL Protein, an Integral Component of Specialized Membranes, in Normal Cells and Cancer.

Authors:  Armando Rubio-Ramos; Leticia Labat-de-Hoz; Isabel Correas; Miguel A Alonso
Journal:  Cells       Date:  2021-04-30       Impact factor: 6.600

Review 8.  Molecular understanding of peripheral T-cell lymphomas, not otherwise specified (PTCL, NOS): A complex disease category.

Authors:  Mamiko Sakata-Yanagimoto; Kota Fukumoto; Kennosuke Karube; Shigeru Chiba
Journal:  J Clin Exp Hematop       Date:  2021-03-15

9.  Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease.

Authors:  Danny W Bruce; Heather E Stefanski; Benjamin G Vincent; Trisha A Dant; Shannon Reisdorf; Hemamalini Bommiasamy; David A Serody; Justin E Wilson; Karen P McKinnon; Warren D Shlomchik; Paul M Armistead; Jenny P Y Ting; John T Woosley; Bruce R Blazar; Dietmar M W Zaiss; Andrew N J McKenzie; James M Coghill; Jonathan S Serody
Journal:  J Clin Invest       Date:  2017-04-04       Impact factor: 14.808

10.  Tumor mutation burden as a biomarker in resected gastric cancer via its association with immune infiltration and hypoxia.

Authors:  Deqiang Wang; Ning Wang; Xiaoqin Li; Xiaofeng Chen; Bo Shen; Dongqin Zhu; Liuqing Zhu; Yaping Xu; Yangyang Yu; Yongqian Shu
Journal:  Gastric Cancer       Date:  2021-03-09       Impact factor: 7.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.